| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |